These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6117651)
21. Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors. Sarantopoulos J; Goel S; Chung V; Munster P; Pant S; Patel MR; Infante J; Tawbi H; Becerra C; Bruce J; Kabbinavar F; Lockhart AC; Tan E; Yang S; Carlson G; Scott JW; Sharma S Cancer Chemother Pharmacol; 2016 Nov; 78(5):921-927. PubMed ID: 27681579 [TBL] [Abstract][Full Text] [Related]
22. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state. Pišlar M; Brelih H; Mrhar A; Bogataj M Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525 [TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers. Podczeck F; Course N; Newton JM; Short MB J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188 [TBL] [Abstract][Full Text] [Related]
24. The administration of L-thyroxine as soft gel capsule or liquid solution. Vita R; Fallahi P; Antonelli A; Benvenga S Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369 [TBL] [Abstract][Full Text] [Related]
25. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration. Bogentoft C; Alpsten M; Ekenved G J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715 [TBL] [Abstract][Full Text] [Related]
27. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers. Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014 [TBL] [Abstract][Full Text] [Related]
28. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults. Nguyen L; Benrimoh N; Xie Y; Offman E; Lacy S Anticancer Drugs; 2016 Aug; 27(7):669-78. PubMed ID: 27139820 [TBL] [Abstract][Full Text] [Related]
30. Dissolution of drugs from solid dosage forms. II. In vitro and in vivo dissolutions. Arayne MS; Sultana N J Pak Med Assoc; 1979 Oct; 29(10):218-26. PubMed ID: 117138 [No Abstract] [Full Text] [Related]
31. Quantitative transmission Raman spectroscopy of pharmaceutical tablets and capsules. Johansson J; Sparén A; Svensson O; Folestad S; Claybourn M Appl Spectrosc; 2007 Nov; 61(11):1211-8. PubMed ID: 18028700 [TBL] [Abstract][Full Text] [Related]
32. Developing Quantitative In Vitro-In Vivo Correlation for Fenofibrate Immediate-Release Formulations With the Biphasic Dissolution-Partition Test Method. Xu H; Shi Y; Vela S; Marroum P; Gao P J Pharm Sci; 2018 Jan; 107(1):476-487. PubMed ID: 28666964 [TBL] [Abstract][Full Text] [Related]
33. Crushing tablets or opening capsules: many uncertainties, some established dangers. Prescrire Int; 2014 Sep; 23(152):209-11, 213-4. PubMed ID: 25325120 [TBL] [Abstract][Full Text] [Related]
34. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets]. Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739 [TBL] [Abstract][Full Text] [Related]
35. Dissolution of drugs from solid dosage forms. I. General aspects. Arayne MS; Sultana N J Pak Med Assoc; 1979 Sep; 29(9):193-200. PubMed ID: 117153 [No Abstract] [Full Text] [Related]
36. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound. Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347 [TBL] [Abstract][Full Text] [Related]
37. Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects. Baldoni D; Mackie A; Gutierrez M; Theodor R; Dingemanse J Clin Ther; 2013 Nov; 35(11):1842-8. PubMed ID: 24095247 [TBL] [Abstract][Full Text] [Related]
38. Before crushing a tablet or opening a capsule... Prescrire Int; 2014 Sep; 23(152):211. PubMed ID: 25325121 [No Abstract] [Full Text] [Related]